Adams Jennifer McKie Insider Trading Activity (ETON)

Summary

Updated Jul 16, 2026

Adams Jennifer McKie has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.62M.

Profile

Jennifer Mckie Adams is a director of Eton Pharmaceuticals, Inc., as disclosed in the company's SEC filings (CIK 0001851440). The most recent filing dated January 14, 2026 shows she holds a board seat with no reported purchases or sales for that period. In this governance role, she contributes to oversight of the specialty pharmaceutical company's activities related to rare-disease products.

Role	Director
Notability	35/100

Board memberships

Eton Pharmaceuticals, Inc.

Awards & honors

Serves on the board of directors for a U.S. specialty pharmaceutical company (Eton Pharmaceuticals, Inc.).
Participates in governance and oversight of corporate strategy for rare-disease products.

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-06-17	ETON	Eton Pharmaceuticals, Inc.	S — Open-market sale	50.0K	$32.48	$1.62M
2026-06-17	ETON	Eton Pharmaceuticals, Inc.	M — Option exercise	50.0K	$3.78	$189K

Frequently Asked Questions

Who is Adams Jennifer McKie?

How many SEC Form 4 filings has Adams Jennifer McKie submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Adams Jennifer McKie been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 1 open-market sales ($1.62M) across all tracked filings.

Where can I see all of Adams Jennifer McKie's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Adams Jennifer McKie — SEC Form 4 Insider Trading Activity